Johnson & Johnson has agreed to pay $33 million to resolve charges by most U.S. states that it misrepresented the manufacturing practices behind Tylenol, Motrin, Benadryl and other over-the-counter drugs that were eventually recalled.
The Complaint filed today by the State of Vermont alleges that Defendants, acting through McNeil, violated Vermont's consumer protection law by misrepresenting their cGMP compliance and the quality of their OTC drugs.
This week, the company settled a deceptive marketing case with 42 states and the District of Columbia, but did not admit any wrongdoing. the governments will share a $33 million settlement from McNeil, and impose limits on how the company can advertise its products. Some of these drugs were recalled three times between 2009 and 2010.
"Federal and state standards are put in place to safeguard consumers from harm but also to maintain quality", said Attorney General Rutledge.
Trump said to praise 'great job' in Philippine drug fight
Duterte also expressed opposition to a 14-year US special operations mission in Mindanao to help fight Muslim extremists. But Trump did reassure Duterte that the US had two "nuclear submarines" stationed in the region.
The lawsuit resulted after McNeil was forced to recall hundreds of millions of packages of drugs it manufactured between 2009 and 2011. Class I recalls involve situations in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. The medicines included brands such as Tylenol, Motrin, St. Joseph Aspirin, Sudafed, Benadryl, Rolaids and Zyrtec.
Santa Fe, NM- This morning, Attorney General Hector Balderas announced that New Mexico will receive $453,474.16 from a settlement with Johnson & Johnson concerning their representations regarding the quality of over-the-counter drugs.
"We will always hold companies accountable for unlawful actions that may jeopardize patient safety", West Virginia Attorney General Patrick Morrisey said in a statement.
McNeil-PPC pleaded guilty in 2015 to introducing adulterated infants' and children's over-the-counter drugs into interstate commerce.